Monthly News Roundup - April 2017

Takeda Announces FDA Accelerated Approval of Alunbrig The US Food and Drug Administration (FDA) has approved once-daily oral Alunbrig (brigatinib) for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news